by Scott Larrivee | Dec 29, 2025 | Blog
Shakespeare said the past is prologue. In that spirit, we submit this look back at 2025. It’s been a year of tremendous progress at Nusano. Our teams are working to enable fields ranging from healthcare to nuclear energy. Every step of the way, we are guided by...
by Scott Larrivee | Jun 26, 2025 | News
The following is a copy of a press release issued by Cellectar Biosciences Partnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for...
